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Abstract – We evaluated the antagonistic eﬀects of newly identiﬁed lactic acid bacteria (LAB) in the gen-
era Lactobacillus and Biﬁdobacterium, originating from the honey stomach, on the honey bee pathogen,
Paenibacillus larvae. We used inhibition assays on agar plates and honey bee larval bioassays to investigate
the eﬀects of honey bee LAB on P. larvae growth in vitro and on AFB infection in vivo. The individual
LAB phylotypes showed diﬀerent inhibition properties against P. larvae growth on agar plates, whereas a
combination of all eleven LAB phylotypes resulted in a total inhibition (no visible growth) of P. larvae.
Adding the LAB mixture to the larval food signiﬁcantly reduced the number of AFB infected larvae in
exposure bioassays. The results demonstrate that honey bee speciﬁc LAB possess beneﬁcial properties for
honey bee health. Possible beneﬁts to honey bee health by enhancing growth of LAB or by applying LAB
to honey bee colonies should be further investigated.
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1. INTRODUCTION
Honey bees, Apis mellifera are the most im-
portant pollinating insect worldwide. Hence,
apiculture has a great economic impact on
insect pollinated crops throughout the world,
and the health status of honey bees has be-
come an important concern in many coun-
tries. There is a large diversity of microor-
ganisms associated with honey bees (Gilliam,
1997) most of them commensals, but some
are pathogens aﬀecting adult bees and brood.
American foulbrood (AFB) is a common bac-
terial disease aﬀecting apiculture worldwide
(Ellis and Munn, 2005). AFB is lethal to in-
fected honey bee larvae, and can be devastat-
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ing to colonies and apiaries causing serious
ﬁnancial losses in apiculture. The disease
is caused by Paenibacillus larvae (Genersch
et al., 2006), a spore-forming, Gram-positive
rod-shaped bacterium that infects young lar-
vae through ingestion of contaminated food.
The bacterial spores germinate and proliferate
in the midgut lumen before they start to breach
the epithelium and invade the haemocoel (Yue
et al., 2008). The colonization of the larval
midgut has been suggested to be one of the
key steps in the pathogenesis of P. larvae (Yue
et al., 2008). Newly hatched larva can become
infected by as few as 10 spores (Woodrow,
1942), but the dosage-mortality relationship is
greatly inﬂuenced by larval age, genetic con-
stitution and bacterial strain (Genersch et al.,
2005). The spore concentrations needed to
cause disease may vary with a factor of at least
20 (Ashiralieva and Genersch, 2006).
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Microbial commensals within host organ-
isms are of great importance and mostly ex-
ist in harmony with the host. Moreover, the
balance of the human microbial ﬂora within
the gastrointestinal tract may be important in
the development of disease (Guarner, 2005).
There are fewer commensals within insects
compared to within humans, but their im-
pact may be even more important. Ryu et al.
(2008) discovered a mutualistic relationship
between the endogenous gut ﬂora and the fruit
ﬂy Drosophila, revealing that the ﬂy’s normal
ﬂora was suﬃcient to suppress the growth of
pathogenic bacteria.
Bacteria belonging to lactic acid bacteria
(LAB) are functionally related by their ability
to produce lactic acid during homo- or hetero-
fermentative metabolism (Klaenhammer et al.,
2002). Lactobacillus and Biﬁdobacterium, two
of the most important genera within LAB,
are commonly found as commensals and are
used as probiotics for humans and animals
(Ouwehand et al., 2002). A novel ﬂora com-
posed of Lactobacillus and Biﬁdobacterium
has recently been identiﬁed in the honey stom-
ach of honey bees, A. mellifera (Olofsson and
Vásquez, 2008; Vásquez et al., 2009). The
phylogenetic analyses performed in both stud-
ies showed the LAB ﬂora in the honey stomach
to be composed of twelve diﬀerent phylotypes.
Furthermore, the ﬁndings revealed that honey
bees and the novel LAB ﬂora evolved in mu-
tual dependence of one another; the LAB ob-
taining a niche in which nutrients are available,
the honey bees and the honey in turn being
protected by the LAB from harmful microor-
ganisms (Olofsson and Vásquez, 2008).
LAB are known to be good producers of an-
timicrobial substances such as organic acids,
hydrogen peroxide and antimicrobial peptides
(de Vuyst and Vandamme, 1994). However,
there is a clear variation in the production
of antimicrobial substances and other beneﬁ-
cial qualities between the diﬀerent species and
genera within LAB (Ouwehand et al., 2002;
Pfeiler and Klaenhammer, 2007). Therefore,
it is important to investigate the potential an-
tagonistic properties of the recently discov-
ered honey bee stomach LAB against speciﬁc
honey bee pathogens.
The purpose of the present study was to in-
vestigate if the newly identiﬁed Lactobacillus
and Biﬁdobacterium phylotypes inhibit growth
of P. larvae and have an eﬀect on AFB disease
development in infected honey bee larvae.
2. MATERIALS AND METHODS
2.1. Paenibacillus larvae strains
Four strains of P. larvae representing four dif-
ferent genotypes based on PCR of conserved motifs
in bacterial repetitive ERIC elements described by
Genersch and Otten (2003) were used in the inhi-
bition experiment (described below). Two of these
isolates were commercially available reference or
type collection strains: LMG 16252 (ERIC III),
LMG 16247 (ERIC IV). The remaining two strains
were isolated from samples of Swedish honey bee
brood with symptoms of AFB (ﬁeld strains) de-
posited at the Culture Collection of the Univer-
sity of Gothenburg as CCUG 48979 (ERIC I) and
CCUG 48972 (ERIC II). The properties of the dif-
ferent genotypes were described by Genersch et al.
(2006). The ﬁeld isolates of P. larvae were also used
for experimentally infecting larvae in bioassays.
Bacterial strains were cultivated on MYPGP-agar
plates as described by Nordström and Fries (1995),
and incubated at 35 ◦C and 5% CO2 for 10–14 days
to obtain sporulation. Fresh spore suspensions were
prepared by suspending bacterial colonies in sterile
0.9% NaCl. A direct microscopic count of the spore
suspensions was made in a Helber Bacteria Count-
ing Chamber (Hawksley) using a phase-contrast
light microscope (400x). Spore suspensions with
concentrations of 5 × 104 and 5 × 105 spores per
milliliter (total microscopic count) were prepared
fresh for each experiment. This corresponds to a vi-
able count of approximately 5 × 103 and 5 × 104
colony forming units (cfu) per mL given that 10% of
the P. larvae spores germinate on solid MYPGP me-
dia (Forsgren et al., 2008). The solutions were fur-
ther diluted in the larval food reaching ﬁnal counted
concentrations of approximately 5×103 and 5×104
spores per mL (5 × 102 and 5 × 103 cfu) respec-
tively (Tab. I).
2.2. Honey bee speciﬁc LAB
Twelve previously found phylotypes derived
from the honey stomachs of honey bees (Olof-
sson and Vásquez, 2008; Vásquez et al., 2009)
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Table I. Diﬀerent treatment groups in the bioassay and the ﬁnal concentration of P. larvae and LAB in the
larval food. Groups 2 and 5 received LAB supplemented food in connection with P. larvae spores (time of
infection = day 0) and all the following days (ﬀ). Groups 3 and 6 received LAB supplemented food day two
post-infection (post inf.) and following days (ﬀ).
Group P. larvae LAB Timing
1 5 × 103 spores/mL -
2 5 × 103 spores/mL 5 × 104 bacteria/mL day 0 ﬀ
3 5 × 103 spores/mL 5 × 104 bacteria/mL day 2 post inf. and ﬀ
4 5 × 104 spores/mL -
5 5 × 104 spores/mL 5 × 104 bacteria/mL day 0 ﬀ
6 5 × 104 spores/mL 5 × 104 bacteria/mL day 2 post inf. and ﬀ
Control - -
were used in the study. Lactobacillus kunkeei
(Fhon2), Biﬁdobacterium asteroides related phy-
lotypes (Hma3, Bin7 and Bin2), Biﬁdobacterium
coryneforme (Bma6) and six Lactobacillus phylo-
types (Hon2, Hma2, Biut2, Bma5, Hma8, Hma11
and Bin4). Individual LAB were inoculated into dif-
ferent broths. Phylotypes Bin2, Bin7, Hma3, Bma6
and Hma11 were inoculated into LCM (Lacto-
bacillus Carrying Media) (Efthymiou and Hansen,
1962). Fhon2 was inoculated into MRS (de Man,
Rogosa and Sharpe, Oxoid) broth supplemented
with 20% fructose. Phylotypes Hon2, Bma5, Hma2,
Biut2, Hma8 and Bin4 were inoculated into MRS
broth (Oxoid) supplemented with 0.5% L-cysteine.
The tubes with the LAB were incubated anaero-
bically at 35 ◦C for 3 days. A mixture containing
all twelve phylotypes in approximately the same
amounts with a total concentration of 107 bac-
teria/mL was prepared and used in the exposure
bioassays.
2.3. Honey bee material
Worker larvae (ﬁrst instar) were collected and
grafted from A. mellifera colonies in the apiary at
the Swedish University of Agricultural Sciences in
Uppsala, Sweden and used in the exposure bioas-
says.
2.4. Inhibition assay
Agar media was prepared for each LAB phylo-
type (phylotype Bin4 was not included in this as-
say). MRS agar (pH 6.2) supplemented with 0.5%
L-cysteine was used for phylotypes Hon2, Hma2,
Bma5, Hma8 and Biut2. MRS agar was used for
phylotypes Bin2, Bin7, Hma3, Bma6 and Hma11.
Tomato juice agar (Oxoid) was used for phylo-
type Fhon2 and the reference strain Lactobacil-
lus kunkeei YH-15T (CCUG 53901). LAB was
grown individually in diﬀerent broths as described
above. Filter paper disks were impregnated with
the individual LAB phylotypes at a ﬁnal concentra-
tion of 106 (for Bma6, Hon2, Hma2), 107 (Fhon2,
Hma8, Biut2, Hma11), and 108 (Bin2, Hma3, Bin7,
Bma5). Each disk was centered on the prepared agar
media. In addition, a ﬁlter paper disk was impreg-
nated with a suspension containing a mixture of all
LAB. The ﬁlter disks were then placed on MRS
agar media. The agar media were incubated anaero-
bically at 35 ◦C for 12 hours. Soft agar of MYPGP
was prepared as previously described (Nordström
and Fries, 1995). The temperature of the soft agar
was adjusted to 42 ◦C. P. larvae spores (ERIC I,
ERIC II, ERIC III and ERIC IV) were mixed with
the soft agar, poured into the agar media contain-
ing the grown LAB and incubated at 35 ◦C and 5%
CO2 for 7 days. Inhibition of P. larvae strains by
LAB was deﬁned as the distance of the paper disks
and the ﬁrst line of P. larvae growth.
2.5. Exposure bioassays
To rear larvae in vitro a protocol by Aupinel
et al. (2005) was followed with minor modiﬁca-
tions. Worker honey bee larvae were reared in 48-
well tissue culture plates on a diet consisting of 50%
royal jelly (v/v) (Stakich, Inc., Bloomﬁeld Hills,
MI, USA), and 50% of an aqueous solution of D-
glucose (12%) and D-fructose (12%). The sugar
was dissolved in sterile deionised water and the
sugar solution was autoclaved at 100 ◦C for 40 min-
utes and kept frozen in aliquots. Before any experi-
ment, the required amount of diet was prepared and
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then stored at +4 ◦C for the duration of the exper-
imental feeding. Before grafting, each plastic well
was supplied with 50 μL of the pre-warmed diet.
The control group was provided with uninfected
diet while the experiment groups were either pro-
vided larval diet spiked with known amounts of P.
larvae spores (groups 1 and 4; Tab. I) or P. larvae
spores mixed with the LAB mixture (groups 2 and
5). First instar worker larvae (less than 24 hours)
were grafted from larval combs and transferred to
the surface of the larval diet of the diﬀerent treat-
ments. Twenty-four hours post exposure to spore
containing diet; all larvae were transferred to wells
containing a diet without P. larvae spores, but were
supplemented with LAB to determine if the timing
of LAB supplements aﬀected the activity against P.
larvae. Two groups of larvae were initially placed
on food with P. larvae spores without addition of
LAB, but received LAB supplemented food from
day two post-infection (groups 3 and 6, Tab. I). Fifty
μL of the supplemented diet was provided to the lar-
vae once a day using a scaled sterile syringe. The
tissue culture plates were kept in plastic boxes with
a wire mesh insert. The boxes were ﬁlled with a
bottom layer of 15.5% glycerol in 0.45% methyl
benzethonium chloride in order to prevent fungal
growth. The larvae were maintained in an incuba-
tor at 35 ◦C with a relative humidity of 96%. On the
7th day, when the larvae generally begun to defe-
cate and spin their cocoon, the 48-well plates were
transferred to boxes where the relative humidity was
kept at 80% through a saturated solution of NaCl al-
lowed to cover the bottom. The boxes were kept in
an incubator at 35 ◦C until the experiment was ﬁn-
ished 14 days post-infection. Throughout the exper-
iment dead larvae were removed daily and cultured
on agar plates to verify presence or absence of P.
larvae.
A total of 1200 larvae were used in ﬁve repeated
experiments.
2.6. Statistical analysis
The response variable in this study was the pro-
portion of infected larvae, hence the eﬀects from
our experimental variables was tested using a gen-
eralization of the ANOVA test using binomial errors
and a logit link function. The generalized ANOVA
was used to evaluate the inﬂuence of LAB, and the
timing and doses of P. larvae spores on the pro-
portion of infected larvae. The statistical evalua-




The combination of all eleven LAB phy-
lotypes resulted in total inhibition (no visible
growth) of all four investigated P. larvae
strains (Tab. II). The individual LAB phy-
lotypes and the reference strainL. kunkeeiT
showed diﬀerent inhibition properties against
P. larvae strains (Tab. II). Two Lactobacillus
phylotypes (Biut 2 and Hma 11) individu-
ally inhibited of all four represented geno-
types. B. coryneforme (Bma 6) totally inhib-
ited the growth of P. larvae genotype ERIC III
and IV (reference strains) whereas there was
no growth inhibition of the isolate of ERIC I
genotype and only partial inhibition of geno-
type ERIC II. Lactobacillus phylotypes BMA
5 totally inhibited growth of P. larvae geno-
types I-III, but resulted in a 1.9 cm inhibition
zone of P. larvae genotype ERIC IV (Fig. 1).
3.2. Exposure bioassays
The overall eﬀect from adding the LAB
mixture to the larval food was a signiﬁ-
cantly reduced number of infected larvae when
pooled data from all experiments, irrespective
of the infective dose, were analyzed (P =
0.007, Fig. 1). The positive eﬀect from adding
LAB to the groups fed larval food with higher
doses of P. larvae (groups 5 and 6) was highly
signiﬁcant (P = 0.005, Fig. 2), however the
diﬀerence among the groups fed lower spore
doses (group 2 and 3) was not (P = 0.198,
Fig. 1).
The ANOVA analysis on the eﬀect of the
time LAB was added to the feed showed no
signiﬁcant diﬀerences on the proportion of in-
fected larvae in any of the treated groups. The
eﬀect of adding LAB in combination with P.
larvae at the time of spore administration was
not signiﬁcantly diﬀerent from adding LAB to
the food 48 hours post infection and through-
out the feeding period.
The total mortality of the uninfected con-
trol group larvae was less than 17% in all the
presented experiments.
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Figure 1. Inhibition from honey bee LAB phylotype Bma 5 (EF187242) on Paenibacillus larvae reference
strain (LMG 16247) genotype ERIC IV.
Figure 2. Proportion infected larvae from all ﬁve experiments (total number infected after 14 days). Data
presented as a mean for groups fed the lower dose P. larvae (group 1); groups fed the lower dose P. larvae
and LAB (groups 2 and 3); groups fed the higher dose P. larvae (group 4); groups fed the higher dose P.
larvae and LAB (groups 5 and 6). The diﬀerence between groups fed the higher dose of P. larvae was
signiﬁcant (P = 0.005). The mortality in the uninfected control group was less than 17% in all experiments.
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4. DISCUSSION
Our results demonstrated a strong in-
hibitory eﬀect of the combined honey bee
stomach LAB ﬂora and of two Lactobacillus
phylotypes (Hma11 and Biut2) on the in vitro
growth of P. larvae (Tab. II). Furthermore,
the results clearly demonstrate that addition of
LAB to young honey bee larvae exposed to P.
larvae spores decreases the proportion of lar-
vae that succumb to AFB infection. Thus, our
results strongly suggest that probiotic bacte-
ria linked to the honey bee stomach have im-
portant implications for honey bee pathology
in general and for AFB tolerance in particu-
lar. Evans and Armstrong (2005, 2006) have
previously shown antagonistic interactions be-
tween honey bee symbionts such as Bacillus
spp. against P. larvae. However, in their stud-
ies no interaction was shown for any of the
honey stomach LAB ﬂora. Members of the
genera Lactobacillus and Biﬁdobacterium are
well known beneﬁcial bacteria widely used as
probiotics to modulate the composition of the
microﬂora in order to protect the host from
infections (Ouwehand et al., 2002). Consid-
ering the colonization of the larval midgut as
a key factor in the pathogenesis of P. lar-
vae (Yue et al., 2008) and the demonstrated
strong inhibitory eﬀect from LAB on P. lar-
vae growth, it is not surprising that the addi-
tion of the honey bee speciﬁc LAB have an
impact on the development of the infection.
In nature, food given to young honey bee lar-
vae contains reduced sugars not present in the
mandibular or hypopharyngeal glands produc-
ing this food (Gontarski, 1960). Probably such
carbohydrates originate from the honey stom-
ach (Townsend and Shuel, 1962) and could
serve as a source for LAB to young larvae.
As the worker larvae grow older (> 3 days),
the worker brood food also contains pollen
(Haydak, 1970). Recently, it was demonstrated
that the honey stomach LAB ﬂora probably
plays a key role in the production of bee
bread from bee pollen (Vásquez and Olofsson,
2009). Bee bread, having a pH between 3.8
and 4.3 and containing organic acids, was ap-
parently fermented by the honey stomach LAB
ﬂora when added to bee pollen via regurgitated
nectar from the honey stomach (Vásquez and
Olofsson, 2009). This discovery shed light on
how the honey bees standardize the produc-
tion of bee bread and shows that the viable
LAB ﬂora is present in signiﬁcant numbers in
fresh bee bread. The LAB and their metabo-
lites are probably transferred to the larvae al-
ready with the ﬁrst food since the larval food
contains carbohydrates not found in the food
producing glands (Gontarski, 1960). A further
boost with LAB is likely administered when
the older larvae also are fed the bee bread.
Such modiﬁcation of the gut microﬂora may
hamper the germination and proliferation of
the P. larvae spores in the larval midgut, thus
preventing the infection. It has been demon-
strated that organic acids at approx. pH 4.2
produced by LAB inhibit germination of spore
forming bacteria (de Vuyst and Vandamme,
1994). Noticeably, during our study it was ob-
vious that the royal jelly used when feeding
the LAB to the larvae exacerbates a negative
inﬂuence on the LAB, preventing their growth
in less than 24 hours (data not shown) proba-
bly due to its low pH (4.0). However, the fact
that addition of fresh LAB to the larval food
signiﬁcantly reduced the proportion of P. lar-
vae infected larvae suggests that the larval gut
conditions allow LAB to be antagonistic to the
pathogen.
The results also demonstrate that not all
LAB inhibit P. larvae, as the reference strain
(L. kunkeei, CCUG 53901) showed only par-
tial inhibition of the P. larvae strain ERIC III-
genotype (Tab. II). It is known that LAB pro-
duce organic acids by their metabolism and
a variety of antagonistic substances including
metabolic end products, antibiotic-like sub-
stances and bactericidal proteins (de Vuyst and
Vandamme, 1994). Furthermore, LAB possess
diﬀerent qualities at the species and strain
level and some of these antagonistic quali-
ties may be situated on unused genes or plas-
mids. Nevertheless, the 16S rDNA sequence
of both the type strain of L. kunkeei and the
honey stomach isolates L. kunkeei Fhon2 are
exactly the same with no single nucleotide
diﬀerence within the entire 16S rRNA gene
(Olofsson and Vásquez, 2008). This means
that the type strain and the isolates from the
honey stomach are the same at the strain level
regarding the 16S rRNA gene. However, there
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were clear diﬀerences between these isolates
when we investigated the entire chromosome
and its protein production (unpublished data).
The fact that the reference strain did not in-
hibit P. larvae may demonstrate that the inhi-
bition properties of L. kunkeei are dependent
on other factors than organic acids. Total in-
hibition of all four P. larvae strains seems to
be achieved by a combination of the factors
mentioned above such as type of metabolic
end products, production of antibacterial pep-
tides or bacteriocins and hydrogen peroxide,
but further investigation is needed to document
these products. It is obvious that the individ-
ual LAB phylotypes inhibit P. larvae strains
diﬀerently (Tab. II). The results suggest that
the entire LAB ﬂora may work in a synergis-
tic manner against P. larvae and possibly also
on other deleterious microorganisms. The dif-
ferences between LAB produced antimicrobial
substances and the inhibition ability of single
LAB members should be further investigated
in vivo as we know that the LAB members
diﬀer in their metabolic pathway (unpublished
data).
Earlier ﬁeld observations demonstrate that
P. larvae infections may be present in honey
bee colonies without producing clinical symp-
toms, and may be reduced from detectable
to non-detectable levels (Fries et al., 2006;
Lindström and Fries, 2005). Actually, an ear-
lier ﬁeld study indicated an inhibition of P. lar-
vae (ERIC I) from LAB when sampling honey
bees obtained from a regular apiary in Swe-
den (Olofsson and Vásquez, 2008). Our results
appear to shed light on these ﬁeld observa-
tions since we demonstrate LAB inhibition of
P. larvae growth on agar plates and decreased
mortality in larvae from AFB when fed LAB.
This suggests that the P. larvae inhibition of
the honey stomach LAB obtained in this work
may be functional also at the colony level in
the ﬁeld.
The ability to inhibit other honey bee
pathogens should be further investigated to
document the full extent of the probiotic prop-
erties of the LAB ﬂora of honey bees. In ad-
dition, strains within Lactobacillus and Biﬁ-
dobacterium possess properties for enhancing
the immune response in humans (Nova et al.,
2007) and in honey bees (Evans and Lopéz,
2004) which could further increase their im-
portance to honey bee health. Furthermore,
it is important to investigate if management
practices, such as antibiotic administration,
may inﬂuence the probiotic ﬂora and poten-
tially lower the threshold for disease establish-
ment.
We can conclude that the newly identiﬁed
probiotic Lactobacillus and Biﬁdobacterium
phylotypes exhibit strong inhibitory eﬀects on
P. larvae growth, and can to some extent pre-
vent symptom development of AFB in honey
bee larvae infected by P. larvae.
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Une nouvelle bactérie lactique inhibant le déve-
loppement de Paenibacillus larvae chez les larves
d’abeille.
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Zusammenfassung – Neue Milchsäurebakteri-
en, die Paenibacillus larvae in Honigbienenlar-
ven hemmen. Die Amerikanische Faulbrut (AFB)
ist eine Krankheit, die junge Honigbienenlarven
befällt. Sie ist eine der schädlichsten Bienen-
krankheiten und hat große ökonomische Bedeu-
tung für die Imkerei weltweit. Der Erreger der
AFB ist das sporenbildende Bakterium Paeniba-
cillus larvae, das den Mitteldarm junger Larven
durch kontaminiertes Futter befällt. Die Besie-
delung des larvalen Mitteldarms stellt einen der
Schlüsselfaktoren für die Pathogenese von P. lar-
vae dar und bestimmte Zusammensetzungen der
Mikroﬂora des Darmes könnten das Wachstum des
Krankheitserregers unterdrücken. Kürzlich wurden
eine neue Flora von Milchsäurebakterien (LAB)
der Gattungen Lactobacillus und Biﬁdobacteri-
um aus dem Honigmagen der Bienen beschrie-
ben. LAB sind zwar bekannt für die Produktion
von antimikrobiellen Substanzen, jedoch gibt es
Variationen bezüglich der nutzbringenden Eigen-
schaften zwischen Arten und Gattungen. In die-
ser Untersuchung wurde der antagonistische Ef-
fekt der Honigbienen-LAB auf P. larvae beur-
teilt. Wir verwendeten Hemmtests auf Agarplatten
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und Biotests mit Honigbienenlarven, um diese
Eﬀekte zu untersuchen. Die individuellen LAB-
Phylotypen zeigten unterschiedliche Hemmeigen-
schaften gegenüber auf Agarplatten wachsenden
P. larvae, während eine Kombination aller 11 LAB-
Phylotypen sogar eine totale Hemmung (kein sicht-
bares Wachstum mehr) von P. larvae bewirkte. Eine
Zugabe des LAB-Mix zum Larvenfutter reduzier-
te signiﬁkant die Anzahl an AFB-inﬁzierten Larven
im Biotest.
Die Ergebnisse zeigen, dass die für Honigbienen
speziﬁschen LAB nutzbringende Eigenschaften für
die Bienengesundheit besitzen. Der mögliche Nut-
zen einer Applikation von LAB in Bienenvölkern
sollte untersucht werden.
Amerikanische Faulbrut / Paenibacillus larvae /
Milchsäurebakterien / Lactobacillus / Biﬁdobac-
terium / Hemmung
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